Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:48:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Minor changes include the addition of Revision: v3.4.2 and the removal of a funding notice, which do not affect the study data, status, or history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T09:22:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and updated the revision history to v3.4.1, removing the previous v3.4.0 entry.
    Difference
    0.9%
    Check dated 2026-02-04T05:38:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, color-coded highlights for additions (green) and deletions (red), and an updated revision label showing v3.4.0.
    Difference
    1%
    Check dated 2026-01-28T04:10:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Record History now shows revision v3.3.4 and removes revision v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:52:29.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T12:32:25.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.